ReviewNeurochemical research2026
Microglia in Perioperative Neurocognitive Disorders: Pathogenic Mechanisms and Emerging Concepts of Microglial Heterogeneity.
Review in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Perioperative neurocognitive disorders (PND) comprise a spectrum of cognitive disturbances after anesthesia and surgery, affecting learning, memory, and executive function. Although systemic inflammation, surgical trauma, anesthetic exposure, and patient vulnerability have been implicated in PND, the mechanisms linking perioperative stress to persistent cognitive changes remain incompletely understood. Microglia, as resident immune cells of the central nervous system, are important regulators of neuroimmune interactions and may contribute to PND through alterations in inflammatory signaling, synaptic regulation, vascular function, metabolism, and epigenetic programs. In this Overview, we summarize current evidence regarding microglial involvement in PND across five interconnected domains: neuroinflammation, blood-brain barrier dysfunction, microglia-neuron communication, mitochondrial and metabolic regulation, and epigenetic remodeling. We further discuss emerging single-cell transcriptomic and multi-omic studies indicating that microglial responses are heterogeneous, dynamic, and context dependent rather than adequately described by the traditional M1/M2 framework. We propose that PND involves complex interactions among peripheral immune activation, neurovascular dysfunction, microglial state transitions, and neuronal vulnerability. Finally, we highlight current challenges in translating microglial mechanisms into clinical applications and discuss future directions for identifying biomarkers and developing context-specific perioperative neuroprotective strategies.
Indexed as
Identifiers
42900258What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.